327 related articles for article (PubMed ID: 34290673)
1. Human Growth and Growth Hormone: From Antiquity to the Recominant Age to the Future.
Graber E; Reiter EO; Rogol AD
Front Endocrinol (Lausanne); 2021; 12():709936. PubMed ID: 34290673
[TBL] [Abstract][Full Text] [Related]
2. Growth and Growth Hormone through the Ages: Art and Science.
Rogol AD; Reiter EO
Horm Res Paediatr; 2022; 95(6):515-528. PubMed ID: 36446319
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone secretion and circulating insulin-like growth factor-I (IGF-I) and IGF binding protein-3 concentrations in children with sickle cell disease.
Soliman AT; el Banna N; alSalmi I; De Silva V; Craig A; Asfour M
Metabolism; 1997 Nov; 46(11):1241-5. PubMed ID: 9361679
[TBL] [Abstract][Full Text] [Related]
4. Status of long-acting-growth hormone preparations--2015.
Høybye C; Cohen P; Hoffman AR; Ross R; Biller BM; Christiansen JS;
Growth Horm IGF Res; 2015 Oct; 25(5):201-6. PubMed ID: 26187188
[TBL] [Abstract][Full Text] [Related]
5. Acromegaly induced by growth hormone replacement therapy.
Karges B; Pfäffle R; Boehm BO; Karges W
Horm Res; 2004; 61(4):165-9. PubMed ID: 14707471
[TBL] [Abstract][Full Text] [Related]
6. Reduced Effectiveness and Comparable Safety in Biweekly
Sun C; Lu B; Liu Y; Zhang Y; Wei H; Hu X; Hu P; Zhao Q; Liu Y; Ye K; Wang K; Gu Z; Liu Z; Ye J; Zhang H; Zhu H; Jiang Z; Liu Y; Wan N; Yan C; Yin J; Ying L; Huang F; Yin Q; Xi L; Luo F; Cheng R
Front Endocrinol (Lausanne); 2021; 12():779365. PubMed ID: 34899612
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.
Hou L; Liang Y; Wu W; Lin HH; Luo XP; Ying YQ
Growth Horm IGF Res; 2020; 53-54():101331. PubMed ID: 32777706
[TBL] [Abstract][Full Text] [Related]
8. The Rationale for Growth Hormone Therapy in Children with Short Stature.
Deodati A; Cianfarani S
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):23-32. PubMed ID: 29280742
[TBL] [Abstract][Full Text] [Related]
9. Indications for growth hormone therapy in children.
Kirk J
Arch Dis Child; 2012 Jan; 97(1):63-8. PubMed ID: 21540481
[TBL] [Abstract][Full Text] [Related]
10. A rationale for the treatment of short stature in children with the combination of recombinant human growth hormone (rhGH) and recombinant human insulin-like growth factor-I (rhIGF-I).
Bright GM; Fierro-Renoy JF
Growth Horm IGF Res; 2020 Jun; 52():101318. PubMed ID: 32252003
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
12. Current indications for growth hormone therapy for children and adolescents.
Richmond E; Rogol AD
Endocr Dev; 2010; 18():92-108. PubMed ID: 20523020
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone therapy: emerging dilemmas.
Laron Z
Pediatr Endocrinol Rev; 2011 Jun; 8(4):364-73. PubMed ID: 21972776
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
Liu HJ; Wang LH; Chen L
Adv Ther; 2019 Sep; 36(9):2374-2383. PubMed ID: 31301056
[TBL] [Abstract][Full Text] [Related]
15. Recombinant growth hormone therapy in children with short stature in Kuwait: a cross-sectional study of use and treatment outcomes.
Al-Abdulrazzaq D; Al-Taiar A; Hassan K; Al-Basari I
BMC Endocr Disord; 2015 Dec; 15():76. PubMed ID: 26630987
[TBL] [Abstract][Full Text] [Related]
16. Approach to the Patient: Safety of Growth Hormone Replacement in Children and Adolescents.
Bamba V; Kanakatti Shankar R
J Clin Endocrinol Metab; 2022 Feb; 107(3):847-861. PubMed ID: 34636896
[TBL] [Abstract][Full Text] [Related]
17. Emerging options in growth hormone therapy: an update.
Kemp SF; Frindik JP
Drug Des Devel Ther; 2011; 5():411-9. PubMed ID: 21966214
[TBL] [Abstract][Full Text] [Related]
18. Assessment of red blood cell indices in growth-hormone-treated children.
Valerio G; Di Maio S; Salerno M; Argenziano A; Badolato R; Tenore A
Horm Res; 1997; 47(2):62-6. PubMed ID: 9030969
[TBL] [Abstract][Full Text] [Related]
19. Six-month, prospective, longitudinal, open-label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement.
Kennedy MJ; Davis DA; Smith N; Gaedigk A; Pearce RE; Kearns GL
Clin Ther; 2008 Sep; 30(9):1687-99. PubMed ID: 18840375
[TBL] [Abstract][Full Text] [Related]
20. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
[No Abstract] [Full Text] [Related]
[Next] [New Search]
